SCHEMBL3346960

SCHEMBL3346960

CCCC(=O)c1ccccc1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 8/20 0.58
WNT3A P56704 8/20 0.58
ERCC5 P28715 1/20 0.56
FEN1 P39748 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.53
KMT2A Q03164 1/20 0.53
CHRM1 P11229 2/20 0.50
CHRM2 P08172 1/20 0.50
CHRM4 P08173 1/20 0.50
HTR1A P08908 1/20 0.50
CHRM5 P08912 1/20 0.50
ADRA2A P08913 1/20 0.50
DRD2 P14416 1/20 0.50
ADRA2B P18089 1/20 0.50
CHRM3 P20309 1/20 0.50
DRD4 P21917 1/20 0.50
ADRA1D P25100 1/20 0.50
ADRA1A P35348 1/20 0.50
HRH1 P35367 1/20 0.50
ADRA1B P35368 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15979740 0.89 CTNNB1 (0.68) CTNNB1WNT3AERCC5FEN1KMT2A
SCHEMBL30089517 0.89 CTNNB1 (0.68) CTNNB1WNT3AERCC5FEN1KMT2A
SCHEMBL4936709 0.88 CHRM1 (0.58) CTNNB1WNT3AERCC5FEN1SMN1; SMN2
SCHEMBL8525198 0.86 CHRM1 (0.57) CTNNB1WNT3AERCC5FEN1KMT2A
SCHEMBL10937745 0.85 CHRM1 (0.56) CTNNB1WNT3AERCC5FEN1KMT2A
SCHEMBL8510526 0.85 CHRM1 (0.56) CTNNB1WNT3AERCC5FEN1KMT2A
SCHEMBL5309095 0.84 CTNNB1 (0.46) CTNNB1WNT3ASMN1; SMN2KMT2AF2R
SCHEMBL8080691 0.84 SMN1; SMN2 (0.51) CTNNB1WNT3AERCC5FEN1SMN1; SMN2
SCHEMBL31901342 0.83 ERCC5 (0.60) CTNNB1WNT3AERCC5FEN1SMN1; SMN2
SCHEMBL364889 0.83 ERCC5 (0.60) CTNNB1WNT3AERCC5FEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108947787-A A kind of total synthesis method of natural products puppet aspidinol 中国药科大学 2018-12-07 CN claimed
CN-108641112-A A kind of preparation method of bamboo plastic chopping board 施文杰 2018-10-12 CN claimed
CN-105440405-B A kind of Wood-plastic composite chopping board and preparation method thereof 费春霞 2017-11-17 CN claimed
CN-106479026-A The preparation method of bamboo plastic chopping board 赤水浩城竹业有限公司 2017-03-08 CN claimed
US-12522696-B2 Bisphenol composition and polycarbonate resin MITSUBISHI CHEMICAL CORPORATION (JP) 2026-01-13 US disclosed
US-12215189-B2 Bisphenol composition and polycarbonate resin MITSUBISHI CHEMICAL CORPORATION (JP) 2025-02-04 US disclosed
CN-113574041-B Bisphenol production method and polycarbonate resin production method 三菱化学株式会社 2023-10-13 CN disclosed
CN-113574042-B Bisphenol composition and polycarbonate resin 三菱化学株式会社 2023-10-13 CN disclosed
US-11427523-B2 Bisphenol composition containing aromatic alcohol sulfonate and method for producing same, polycarbonate resin and method for producing same, and bisphenol production method MITSUBISHI CHEMICAL CORPORATION (JP) 2022-08-30 US disclosed
US-20220098135-A1 BISPHENOL COMPOSITION AND POLYCARBONATE RESIN MITSUBISHI CHEMICAL CORPORATION (JP) 2022-03-31 US disclosed
EP-3939957-A1 BISPHENOL COMPOSITION AND POLYCARBONATE RESIN Mitsubishi Chemical Corporation (JP) 2022-01-19 EP disclosed
EP-3940015-A1 BISPHENOL COMPOSITION AND POLYCARBONATE RESIN Mitsubishi Chemical Corporation (JP) 2022-01-19 EP disclosed
US-7241757-B2 Amidino derivatives and their use as thrombin inhibitors ASTRAZENECA AB (SE) 2007-07-10 US disclosed
US-20060276329-A1 Asymmetric synthesis catalyst based on chiral brsnsted acid and method of asymmetric synthesis with the catalyst TOAGOSEI CO., LTD. (JP) 2006-12-07 US disclosed
EP-1623971-A1 ASYMMETRIC-SYNTHESIS CATALYST BASED ON CHIRAL BROENSTED ACID AND METHOD OF ASYMMETRIC SYNTHESIS WITH THE CATALYST TOAGOSEI CO., LTD. (JP) 2006-02-08 EP disclosed
EP-1038877-B1 Binaphthol monophosphoric acid derivative and its use TOSOH CORP (JP) 2004-03-10 EP disclosed
US-6274745-B1 CATALYST TOSOH CORPORATION (JP) 2001-08-14 US disclosed
EP-0013726-B1 INDANYLOXAMIC DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SANDOZ AG (CH) 1982-09-29 EP disclosed
US-4330555-A Indanyloxamic derivatives, their preparation and pharmaceutical compositions containing them SANDOZ LTD. (CH) 1982-05-18 US disclosed
EP-0013726-A1 Indanyloxamic derivatives, their preparation and pharmaceutical compositions containing them SANDOZ AG (CH) 1980-08-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12215189-B2 Bisphenol composition and polycarbonate resin SUZ12, RB1, RRP12 CTNNB1 2076/4885WNT3A 4276/4885ERCC5 1416/4885
US-20220098135-A1 BISPHENOL COMPOSITION AND POLYCARBONATE RESIN MRPS22, RBBP4, RBBP7 CTNNB1 3674/4885WNT3A 4406/4885ERCC5 522/4885
US-20060276329-A1 Asymmetric synthesis catalyst based on chiral brsnsted acid and method of asymmetric synthesis with the catalyst LSS, COASY, FASN CTNNB1 1593/4885WNT3A 2416/4885ERCC5 3615/4885
US-11427523-B2 Bisphenol composition containing aromatic alcohol sulfonate and method for producing same, polycarbonate resin and method for producing same, and bisphenol production method ASH2L, FHIT, ADH1C CTNNB1 4269/4885WNT3A 4846/4885ERCC5 1949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.